High mammographic density is associated with an increased risk of breast cancer, however whether the association is stronger when there is agreement across measures is unclear. This study investigates whether a combination of density measures is a better predictor of breast cancer risk than individual methods alone. Women recruited to the Predicting Risk of Cancer At Screening (PROCAS) study and with mammographic density assessed using three different methods were included (n=33,304). Density was assessed visually using Visual Analogue Scales (VAS) and by two fully automated methods, Quantra and Volpara. Percentage breast density was divided into (high, medium and low) and combinations of measures were used to further categorise individuals (e.g. 'all high'). A total of 667 breast cancers were identified and logistic regression was used to determine the relationship between breast density and breast cancer risk. In total, 44% of individuals were in the same tertile for all three measures, 8.6% were in non-adjacent (high and low) or mixed categories (high, medium and low). For individual methods the strongest association with breast cancer risk was for medium and high tertiles of VAS with odds ratios (OR) adjusted for age and BMI of 1.63 (95% CI 1.31-2.03) and 2.33 (1.87-2.90) respectively. For the combination of density methods the strongest association was for 'all high' (OR 2.42, 1.77-3.31) followed by "two high" (OR 1.90, 1.35-3.31) and "two medium" (OR 1.88, 1.40-2.52). Combining density measures did not affect the magnitude of risk compared to using individual methods.
INTRODUCTION
Breast density is defined as the proportion of fibroglandular tissue present in the breast, and the risk of breast cancer is three to five fold higher in those with the highest breast density compared to those with the lowest breast density 1 . In addition, high breast density may lead to the risk of cancer being missed as a result of masking 2 . Previous studies investigating the relationship between breast density and breast cancer risk have largely been based on analogue mammograms measuring percent area density and mainly involving qualitative assessment techniques such as the Breast Imaging Reporting and Data System (BI-RADS) 3 or using digitized film mammograms and semi-automated thresholding techniques, such as Cumulus 4, 5 . More recently the advent of full field digital mammography (FFDM) has enabled the use of volumetric methods for breast density measurement. A recent study examining the relationship between different density measures and the risk of breast cancer using odds ratios (OR) per standard deviation (SD) found percentage density was highest for Volpara ( 6 . This study also combined pairs of readings from automated methods and found no effect on the magnitude of the risk association.
We hypothesised that individuals who score high on three measures of breast density (VAS, Volpara and Quantra) would have a greater risk of developing breast cancer than those who score medium or low on the same measures. The aim of this study was to investigate whether the agreement between breast density methods provide a better estimate of breast cancer risk than individual methods of measuring breast density alone. More specifically, this study aimed to categorise breast density as high, medium or low according to three measures of breast density (VAS, Volpara and Quantra) and to use these categories, and combinations of categories, to determine breast cancer risk.
METHODS
Women recruited to the Predicting Risk Of Cancer At Screening (PROCAS) study between October 2009 to March 2015 were included in the study if they had breast density measured by the three methods. The PROCAS study is a large prospective study of 57,904 women who were invited to the National Health Service Breast Screening Programme (NHSBSP) and consented to take part in the study. Participants were asked to complete a two-page questionnaire at the time of screening which included information on demographics, personal history and hormonal, reproductive and lifestyle risk factors. Breast density at the time of screening was assessed using three different methods for 33,304 women. The outcome for the study was the diagnosis of breast cancer. Breast cancers were identified from clinical databases and by participants themselves.
ANALYSIS
Each density measurement was divided into tertiles (low, medium and high) and two new variables were created to further categorise breast density -one for volumetric methods and one for all three measurement methods. For volumetric methods (Volpara and Quantra) participants were grouped as being "both low", "both medium", "both high" or as "mixed". Meanwhile participants in the same tertiles for all three measurement methods were classed as being "all low", "all medium" or "all high". If two methods agreed, participants were classed as "two low", "two medium" or "two high". If all the methods disagreed (high, medium, low) these were classed as "mixed".
Individual logistic regressions were performed for individual measures of breast density (i.e. separate regressions for VAS, Volpara and Quantra); volumetric methods (Volpara and Quantra combined) and for all three methods (combination of VAS, Volpara and Quantra). Logistic regressions were adjusted for age and body mass index (BMI).
RESULTS
At the time of analysis 667 women had breast cancer and 32637 were breast cancer free. Women with breast cancer were significantly older than those without breast cancer with a mean (SD) age of 59.5 (6.9) years and 58.4 (7.1) years respectively. Those with breast cancer also had a significantly raised body mass index (BMI in kg/m 2 ) compared to those without (mean (SD) BMI of 28.0 (5.3) and 27.5 (5.6) respectively). Further analyses were adjusted for age and BMI. There were no significant differences between the groups in terms of HRT use (31.0 and 8.5% of women with cancer were previous and current users respectively, compared with 30.8% and 7.4% of those without); parity (86.6% of women with cancer and 88.1% of those without had children) and menopausal status (75.4% of women with cancer were postmenopausal compared to 71.7% in those without). The median percent density scores (women with and without cancer combined) were 24.4% for VAS, 5.4% for Volpara and 10.2% for Quantra.
Agreement between methods

Figure 1: Agreement (%) between VAS, Volpara and Quantra
Volumetric methods -results for only volumetric methods showed that nearly two thirds of participants (64.9%) were in the same category (low-low, medium-medium or high-high) and the combination of extreme categories (low and high) was rare (2.8%).
Agreement between three methods -the extent of agreement between low, medium and high categories for the three methods is shown in figure 1 . All methods agreed for 43.7% participants. In 47.9% of participants, two methods agreed whilst the third method put them an adjacent category (low and medium, or medium and high). Only 3.2% of the cohort had a combination of extremes (low and high) while 5.4% were classified as 'mixed' (i.e. low, medium and high).
Results from the logistic regression
Individual measures of breast density -compared to the reference category (low), each "medium" and "high" category for VAS, Volpara and Quantra had a significantly increased odds of developing breast cancer after adjusting for age and BMI. VAS showed the strongest association, with odds ratios (OR) of 1.63 (95% CI 1.31-2.03) and 2.33 (1.87-2.90) for the medium and high tertiles respectively. Volumetric methods showed more modest ORs of 1.54 (1.25-1.91) and 1.89 (1.50-2.40) for Volpara and 1.25 (1.02-1.53) and 1.57 (1.28-1.93) for Quantra for medium and high tertiles respectively. For each individual method, compared to the lowest tertile the odds of breast cancer risk was statistically significant increased for both the medium and high tertiles (p values all <0.05).
Volumetric methods -compared to participants scoring low on both Volpara and Quantra, the odds of breast cancer was 1.54 (1.17-2.01) and 1.89 (1.45-2.46) for those scoring medium and high on both methods. The mixed group had an odds ratio of 1.44 (1.13-1.82). All groups were significantly different (p<0.01) from the reference category (both low). All three methods -compared to the reference category (all low), the odds of breast cancer for the "mixed" category was 1.64 (1.07-2.50). Scoring "two medium" produced a greater OR than scoring "all medium" and was similar to scoring "two high" (1.88, 1.65 and 1.90 respectively). The "all high" category produced the highest OR (2.42, 1.77-3.31). The result for the "two low" category was not statistically significant, while all other categories were statistically significantly different to the "all low" group (p values all <0.05) (Figure 2 ).
DISCUSSION
This study aimed to investigate whether a combination of breast density measurements, namely, VAS, Volpara and Quantra, predict breast cancer risk better than individual methods alone. The best individual predictor of breast cancer risk was VAS. VAS was also better than a combination of automated methods, Volpara and Quantra. The combination of all three methods did not affect the magnitude of the association. This finding is similar to that of Eng et al. (2014) who found that combinations of pairs of automated density methods did not affect the strength of the association between percent density and breast cancer risk. 6 The strengths of this study include the large sample size, including a sizeable number of breast cancers, for whom breast density was measured using three different methods, including two volumetric methods as well as an area based visually assessed method. Volumetric methods eliminate the potential for subjectivity, however VAS was a better predictor of breast cancer risk despite its subjective nature, and the potential for inter and intra observer variability. This may be as a result of qualitative aspects observed by readers on mammograms e.g. readers may attribute higher scores due to factors such as texture, distribution of fibroglandular tissue, or any suspicious features of breast cancer such as microcalcifications or asymmetry.
The limitations of this study are that it was not possible to determine the temporal relationship between breast density and outcome. Breast cancer may have been diagnosed at entry to the PROCAS study (i.e. at the time of the mammogram at entry to PROCAS), between screens or at a subsequent screen. Consequently, density measures of patients diagnosed at entry to the PROCAS study may have been affected by the presence of the breast cancer. As such, one would ideally look separately at those diagnosed at the time of entry to PROCAS, and those diagnosed subsequently.
Another limitation of the PROCAS study is the relatively low recruitment rate (38% of the total screened population). This may have led to selection bias, in that there may be a difference between those who did and did not agree to participate in PROCAS. For example, women with a family history of breast cancer may be more likely participate than those without a family history. If this difference is systematically different for responders and nonresponders then this may affect the external validity of the study, and the results may not be representative of the population as a whole.
In total, we found that density measures agreed 44% of the time and for a further 48% of the time two methods agreed with the third method placing them in an adjacent category. Reassuringly, the combination of extremes (low and high) and 'mixed' categories (high, medium and low) was minimal. It would, however, be interesting to investigate further those in the extreme and mixed categories to determine whether it is one particular method that is consistently different or whether differences exist due to artefacts of the imaging process, such as issues to do with positioning (inframammary folds, pectoralis major and nipple visibility) and radiographic procedures (tube voltage, tube current, compression thickness and force). 7 In the future it would be of interest to investigate the relationship between combinations of density methods using other measures of breast density, such as fibroglandular volume, and the risk of breast cancer. Other strategies for combining density methods could also be explored. While in this study we used the combined average across readers for VAS, we could also randomly choose the result for one reader.
CONCLUSION
As an individual method, VAS predicted breast cancer risk better than Volpara or Quantra. VAS also fared better than a combination of Volpara and Quantra. The combination of all three methods did not change the magnitude of association compared to VAS alone.
